Aspira Pathlab & Diagnostics informs about disclosure

02 Mar 2024 Evaluate

Aspira Pathlab & Diagnostics has informed that it enclosed the following disclosure Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Nikunj Velji Mange (DIN: 08489442), Executive Director of the Company for the acquisition of Equity Shares from the market.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

67.00 2.87 (4.48%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7235.90
Max Healthcare Inst 1036.55
Narayana Hrudayalay 1918.80
Aster DM Healthcare 599.60
Global Health 1144.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×